Literature DB >> 17125851

Vulnerable windows for developmental ethanol toxicity in the Japanese medaka fish (Oryzias latipes).

Sharon L Oxendine1, John Cowden, David E Hinton, Stephanie Padilla.   

Abstract

Ethanol (EtOH) is a well-known developmental toxicant that produces a range of abnormal phenotypes in mammalian systems including craniofacial abnormalities, cognitive deficits and growth retardation. While the toxic potential of developmental EtOH exposure is well characterized clinically, the effect of timing on the extent of toxicity remains unknown. Fish models such as the Japanese medaka, Oryzias latipes, provide a convenient system for investigating the effects of developmental EtOH exposure in vivo. In this study, medaka embryo toxicity tests were used to assess temporal variations in developmental EtOH toxicity. Fertilized eggs were collected and incubated during early, middle or late egg development (e.g., 0-3, 3-6 or 6-9 days post-fertilization) with various sub-lethal concentrations of EtOH [0.1% (17.2 mM), 0.5% (86.0 mM) or 1% (172 mM)]. Uptake of EtOH by the embryo was 60-68% of the solution concentration across all windows. Time to hatch, head width, total body length and whole embryo caspase activity were used to assess toxicity. Hatching delays were noted only at the highest concentration of EtOH. Head width was affected at all ethanol levels, regardless of the window of exposure. EtOH-induced decreases in body length, however, appeared to be most pronounced when exposure occurred either during the first or last window. The effect on caspase-3/7 activity also depended on the window of exposure, with increases in caspase noted in embryos treated on days 1 or 2 (first window) and decreases seen in embryos treated on day 6 (second window) or day 8 (third window). In general, these data suggest that critical periods for heightened sensitivity to developmental EtOH exposure may vary according to the specific endpoint used to assess toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125851     DOI: 10.1016/j.aquatox.2006.10.007

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  7 in total

Review 1.  Zebrafish models of fetal alcohol spectrum disorders.

Authors:  Yohaan Fernandes; C Ben Lovely
Journal:  Genesis       Date:  2021-11-05       Impact factor: 2.389

2.  Disruption of circulation by ethanol promotes fetal alcohol spectrum disorder (FASD) in medaka (Oryzias latipes) embryogenesis.

Authors:  Yuhui Hu; Ikhlas A Khan; Asok K Dasmahapatra
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-06-22       Impact factor: 3.228

3.  Ethanol teratogenesis in Japanese medaka: effects at the cellular level.

Authors:  Minghui Wu; Amit Chaudhary; Ikhlas A Khan; Asok K Dasmahapatra
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2007-09-16       Impact factor: 2.231

4.  Ethanol disrupts chondrification of the neurocranial cartilages in medaka embryos without affecting aldehyde dehydrogenase 1A2 (Aldh1A2) promoter methylation.

Authors:  Yuhui Hu; Kristine L Willett; Ikhlas A Khan; Brian E Scheffler; Asok K Dasmahapatra
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2009-08-03       Impact factor: 3.228

5.  Differential developmental toxicity of naphthoic acid isomers in medaka (Oryzias latipes) embryos.

Authors:  Michael W Carney; Kyle Erwin; Ron Hardman; Bonny Yuen; David C Volz; David E Hinton; Seth W Kullman
Journal:  Mar Pollut Bull       Date:  2008-04-22       Impact factor: 5.553

6.  A Drosophila model for fetal alcohol syndrome disorders: role for the insulin pathway.

Authors:  Kimberly D McClure; Rachael L French; Ulrike Heberlein
Journal:  Dis Model Mech       Date:  2011-02-08       Impact factor: 5.758

7.  Stepwise embryonic toxicity of silver nanoparticles on Oryzias latipes.

Authors:  Jae-Gu Cho; Kyung-Tae Kim; Tae-Kwon Ryu; Jae-woo Lee; Ji-Eun Kim; Jungkon Kim; Byoung-Cheun Lee; Eun-Hye Jo; Junheon Yoon; Ig-chun Eom; Kyunghee Choi; Pilje Kim
Journal:  Biomed Res Int       Date:  2013-07-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.